Neutrophil Gelatinase–Associated Lipocalin Acts as a Robust Early Diagnostic Marker for Renal Replacement Therapy in Patients with Russell’s Viper Bite–Induced Acute Kidney Injuries
Authors:
- Subramanian SenthilkumaranSubramanian Senthilkumaran
- Ketan PatelKPKetan Patel
- Anika SalimASAnika Salim
- Pradeep VijayakumarPVPradeep Vijayakumar
- Harry F. WilliamsHWHarry F. Williams
- Rajendran VaiyapuriRVRajendran Vaiyapuri
- Ravi SavaniaRSRavi Savania
- Namasivayam ElangovanNENamasivayam Elangovan
- Ponniah ThirumalaikolundusubramanianPTPonniah Thirumalaikolundusubramanian
- M. Fazil BakshMBM. Fazil Baksh
- Sakthivel VaiyapuriSakthivel Vaiyapuri
Open Access
Abstract
Snakebite-induced acute kidney injury (AKI) is frequently observed in patients following bites from vipers such as Russell’s viper (Daboia russelii) in India. Currently, the levels of serum creatinine are mainly used as a marker to determine the necessity for renal replacement therapy (RRT) (haemodialysis) in severe cases of AKI. However, it takes up to 48 h to ascertain a distinct change in creatinine levels compared to its baseline level upon admission. The time lost between admission and the 48 h timepoint significantly affects the clinical management of snakebite victims. Moreover, early diagnosis of AKI and decision on the necessity for RRT in snakebite victims is critical in saving lives, reducing long-term complications, and minimising treatment costs arising from expensive haemodialysis. Neutrophil gelatinase–associated lipocalin (NGAL) has been recently studied as a robust early marker for AKI in non-snakebite patients. However, its suitability for clinical use in snakebite victims has not been rigorously established. Here, we demonstrate the clinical significance of plasma NGAL as a robust marker for RRT following AKI using a large cohort (309) of Russell’s viper victims without any pre-existing health conditions. NGAL levels upon admission are positively correlated with creatinine levels at 48 h in different stages of AKI. Overall, NGAL acts as a robust early marker to ascertain the need for RRT following Russell’s viper bites. The quantification of NGAL can be recommended as a routine test in hospitals that treat snakebites to decide on RRT at early time points instead of waiting for 48 h to confirm the increase in creatinine levels. The diagnostic use of NGAL in Russell’s viper victims with pre-existing comorbidities and for other vipers should be evaluated in future studies.Keywords
This publication has 43 references indexed in Scilit:
- Snakebite and Its Socio-Economic Impact on the Rural Population of Tamil Nadu, IndiaPLOS ONE, 2013
- The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injuryIntensive Care Medicine, 2013
- A Study on the Acute Kidney Injury in Snake Bite Victims in A Tertiary Care CentreJournal of Clinical and Diagnostic Research, 2013
- Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI)American Journal of Physiology-Renal Physiology, 2011
- Snakebite Mortality in India: A Nationally Representative Mortality SurveyPLOS Neglected Tropical Diseases, 2011
- The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and DeathsPLOS Medicine, 2008
- Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney DamageAmerican Journal of Kidney Diseases, 2008
- Conventional markers of kidney functionCritical Care Medicine, 2008
- Serum neutrophil gelatinase‐associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery diseaseNephrology, 2008
- Biomarkers of Acute Kidney InjuryAnnual Review of Pharmacology and Toxicology, 2008